References
- Jacobson RM, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA. Independence of measles-specific humoral and cellular immune responses to vaccination. Hum. Immunol. 73, 474–479 (2012).
- Chen RT, Markowitz LE, Albrecht P et al. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 162(5), 1036–1042 (1990).
- Samb B, Aaby P, Whittle HC et al. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr. Infect. Dis. J. 14(3), 203–209 (1995).
- Permar SR, Moss WJ, Ryon JJ et al. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J. Infect. Dis. 183(4), 532–538 (2001).
- Permar SR, Klumpp SA, Mansfield KG et al. Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J. Virol. 77(7), 4396–4400 (2003).
- de Vries RD, Yüksel S, Osterhaus ADME, de Swart RL. Specific CD8(+) T-lymphocytes control dissemination of measles virus. Eur. J. Immunol. 40(2), 388–395 (2010).
- Permar SR, Griffin DE, Letvin NL. Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals. Clin. Vaccine Immunol. 13(4), 437–443 (2006).
- Ward BJ, Boulianne N, Ratnam S, Guiot MC, Couillard M, De Serres G. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J. Infect. Dis. 172(6), 1591–1595 (1995).
- Bautista-López N, Ward BJ, Mills E, McCormick D, Martel N, Ratnam S. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine 18(14), 1393–1401 (2000).
- Muller CP, Huiss S, Schneider F. Secondary immune responses in parents of children with recent measles. Lancet 348(9038), 1379–1380 (1996).
- Helfand RF, Kim DK. Gary HE Jr et al. Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J. Med. Virol. 56(4), 337–341 (1998).
- Dhiman N, Ovsyannikova IG, Ryan JE et al. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles–mumps–rubella-II (MMR-II) vaccination. Clin. Exp. Immunol. 142(3), 498–504 (2005).
- Haralambieva IH, Ovsyannikova IG, Kennedy RB et al. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine 29(45), 7883–7895 (2011).
- Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum. Genet. 130(4), 547–561 (2011).
- Haralambieva IH, Ovsyannikova IG, Vierkant RA, Poland GA. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity. Clin. Vaccine Immunol. 15(7), 1054–1059 (2008).
- Ryan JE, Ovsyannikova IG, Poland GA. Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT. Methods Mol. Biol. 302, 207–218 (2005).
- Amanna IJ, Slifka MK. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology 411(2), 206–215 (2011).
- van Baalen CA, Gruters RA, Berkhoff EG, Osterhaus ADME, Rimmelzwaan GF. FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity. Cytometry. A 73(11), 1058–1065 (2008).
- Kreijtz JHCM, de Mutsert G, van Baalen CA, Fouchier RAM, Osterhaus ADME, Rimmelzwaan GF. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J. Virol. 82(11), 5161–5166 (2008).
- Sheridan BS, Lefrançois L. Regional and mucosal memory T cells. Nat. Immunol. 12(6), 485–491 (2011).